Bortezomib combined with histone deacetylase inhibitor ITF2357 or arsenic trioxide exerts aynergistic anti-proliferative and pro-apoptotic effect on P39 cells

---

Savli H., Galimberti S., Canestraro M., Nagy B., Palumbo G. A. , Petrini M.

JOURNAL OF CLINICAL ONCOLOGY, vol.26, 2008 (Journal Indexed in SCI)

• Publication Type: Article / Abstract
• Volume: 26 Issue: 15
• Publication Date: 2008
• Doi Number: 10.1200/jco.2008.26.15_suppl.18022
• Title of Journal : JOURNAL OF CLINICAL ONCOLOGY